http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CH-613697-A5

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D243-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D243-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
filingDate 1975-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_268cc853cef6ec798a7ecd2b7d162e58
publicationDate 1979-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CH-613697-A5
titleOfInvention Process for the preparation of novel 5-amino-7-phenyl-2,3-dihydro-1H-1,4-diazepines
abstract Novel 5-amino-7-phenyl-2,3-dihydro-1H-1,4-diazepines of the formula I <IMAGE> in which either R1 is H, alkyl or amino and R2 is H or alkyl or R1 and R2 together with N form, inter alia, a pyrrolidine or piperidine ring, and R3, R4 and R5 are H, alkyl, alkoxy or halogen, or two adjacent substituents form a methylenedioxy group, are prepared by reacting corresponding compounds of the formula II <IMAGE> in which R' is primary or secondary alkyl, with amines of the formula HNR1R2 The compounds are active against obesity and have an antidiabetic effect.
priorityDate 1974-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20521325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410310677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136468751
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12834621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425978009
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3298746
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449843216
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12834620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723982
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20521342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20521341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551550
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413650529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409762621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465617613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465607263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420433585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415792852
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559091
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409769823

Total number of triples: 52.